Exiqon launches new Hi-Power microRNA labeling kits

Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of the 3rd generation of miRCURY LNATM microRNA Labeling Kit called Hi-Power for labeling of microRNAs for downstream hybridization to microRNA arrays.

The new Hi-Power microRNA labeling kits increase the signal intensity (signal-to-noise) of the labeling up to 2 fold. This enables users of the miRCURY LNATM microRNA Array platform to use substantial less total RNA sample (down to half the amount) in order to obtain the same level of microRNA profiling compared to using the previous labeling kits and yet detect more microRNAs expressed at very low levels.

"The launch of the new labeling kits provides our customers with the most sensitive microRNA Array platform available on the market" said Vice President Sales & Marketing, Dr. Henrik M. Pfundheller and added: "Together with the recent launch of the 6th generation miRCURY LNATM microRNA Arrays having a full coverage of miRBase 16 for human, mouse and rat, Exiqon clearly has taken the lead in offering microRNA researchers the most valuable solution for microRNA profiling using microarrays".

SOURCE Exiqon A/S

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals how neuropilin2 gene influences autism and epilepsy development